Friday, 22 January 2010

Indian pharma sector "fares well" in US disputes

India's Financial Express reports ("Domestic pharma cos fare well in patent litigation tests") on the pharma patent litigation success rates of India's leading pharmaceutical companies in US litigation over the past decade. Lupin Pharma has a success rate of 75%, while Sun Pharma (67%), Ranbaxy (63%) and Dr Reddy’s (61%) are not far behind. The article also gives a neat thumbnail sketch of the pharma patent litigation environment.

2 comments:

Anonymous said...

Is anyone else inappropriately amused by Lupin's logo? Do they, perhaps, sell a generic equivalent of Viagra?

Dhananjay Rau said...

bawmothLupin's logo was concieved (pun not intended) decades before Viagra was even a twinkle in its inventor's eyes !!!!!!